176 related articles for article (PubMed ID: 31267315)
1. Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?
Stamati P; Siokas V; Aloizou AM; Karampinis E; Arseniou S; Rakitskii VN; Tsatsakis A; Spandidos DA; Gozes I; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2019 Oct; 69(2):343-350. PubMed ID: 31267315
[TBL] [Abstract][Full Text] [Related]
2. Lack of an association between SCFD1 rs10139154 polymorphism and amyotrophic lateral sclerosis.
Siokas V; Aloizou AM; Liampas I; Bakirtzis C; Nasios G; Paterakis K; Sgantzos M; Bogdanos DP; Spandidos DA; Tsatsakis A; Mitsias PD; Dardiotis E
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35234271
[TBL] [Abstract][Full Text] [Related]
3. An association study between SCFD1 rs10139154 variant and amyotrophic lateral sclerosis in a Chinese cohort.
Chen Y; Zhou Q; Gu X; Wei Q; Cao B; Liu H; Hou Y; Shang H
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):413-418. PubMed ID: 29260601
[TBL] [Abstract][Full Text] [Related]
4. A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
Andersson CH; Hansson O; Minthon L; Andreasen N; Blennow K; Zetterberg H; Skoog I; Wallin A; Nilsson S; Kettunen P
J Alzheimers Dis; 2016 Jul; 53(4):1353-63. PubMed ID: 27392867
[TBL] [Abstract][Full Text] [Related]
5. Loss of amyotrophic lateral sclerosis risk factor SCFD1 causes motor dysfunction in Drosophila.
Borg R; Purkiss A; Cacciottolo R; Herrera P; Cauchi RJ
Neurobiol Aging; 2023 Jun; 126():67-76. PubMed ID: 36944290
[TBL] [Abstract][Full Text] [Related]
6.
Iacoangeli A; Fogh I; Selvackadunco S; Topp SD; Shatunov A; van Rheenen W; Al-Khleifat A; Opie-Martin S; Ratti A; Calvo A; ; Van Damme P; Robberecht W; Chio A; Dobson RJ; Hardiman O; Shaw CE; van den Berg LH; Andersen PM; Smith BN; Silani V; Veldink JH; Breen G; Troakes C; Al-Chalabi A; Jones AR
Brain Commun; 2021; 3(4):fcab236. PubMed ID: 34708205
[TBL] [Abstract][Full Text] [Related]
7. SLC2A3 rs12842 polymorphism and risk for Alzheimer's disease.
Arseniou S; Siokas V; Aloizou AM; Stamati P; Mentis AA; Tsouris Z; Dastamani M; Peristeri E; Valotassiou V; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurol Res; 2020 Oct; 42(10):853-861. PubMed ID: 32627711
[TBL] [Abstract][Full Text] [Related]
8. A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease.
Laumet G; Petitprez V; Sillaire A; Ayral AM; Hansmannel F; Chapuis J; Hannequin D; Pasquier F; Scarpini E; Galimberti D; Lendon C; Campion D; Amouyel P; Lambert JC
Neurosci Lett; 2010 Jan; 468(1):1-2. PubMed ID: 19837132
[TBL] [Abstract][Full Text] [Related]
9. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
10. Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues.
Alachkar H; Kataki M; Scharre DW; Papp A; Sadee W
Neurosci Lett; 2008 Dec; 448(1):120-4. PubMed ID: 18938222
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.
Wang Z; Lei H; Zheng M; Li Y; Cui Y; Hao F
Mol Neurobiol; 2016 Nov; 53(9):6501-6510. PubMed ID: 26611835
[TBL] [Abstract][Full Text] [Related]
12. Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis.
Chen Y; Li S; Su L; Sheng J; Lv W; Chen G; Xu Z
J Neurol; 2015; 262(4):814-22. PubMed ID: 25578179
[TBL] [Abstract][Full Text] [Related]
13. rs2070424 of the SOD1 gene is associated with risk of Alzheimer's disease.
Spisak K; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Aleksandra G; Slowik A
Neurol Neurochir Pol; 2014; 48(5):342-5. PubMed ID: 25440013
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
Yin Y; Liu Y; Pan X; Chen R; Li P; Wu HJ; Zhao ZQ; Li YP; Huang LQ; Zhuang JH; Zhao ZX
PLoS One; 2016; 11(3):e0149945. PubMed ID: 26937653
[TBL] [Abstract][Full Text] [Related]
15. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
[TBL] [Abstract][Full Text] [Related]
16. Variants of Base Excision Repair Genes MUTYH , PARP1 and XRCC1 in Alzheimer's Disease Risk.
Kwiatkowski D; Czarny P; Galecki P; Bachurska A; Talarowska M; Orzechowska A; Bobińska K; Bielecka-Kowalska A; Pietras T; Szemraj J; Maes M; Sliwinski T
Neuropsychobiology; 2015; 71(3):176-86. PubMed ID: 25998844
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
[TBL] [Abstract][Full Text] [Related]
18. The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.
Zhou F; Wang D
Oncotarget; 2017 Jun; 8(26):43506-43520. PubMed ID: 28415654
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PTPRK polymorphisms in association with risk and age at onset of Alzheimer's disease, cancer risk, and cholesterol.
Chen Y; Xu C; Harirforoosh S; Luo X; Wang KS
J Psychiatr Res; 2018 Jan; 96():65-72. PubMed ID: 28987514
[TBL] [Abstract][Full Text] [Related]
20. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
Amber S; Zahid S
Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
